BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25065639)

  • 21. Spritzer: For diagnostic cytopathology.
    Metgud R; ; Naik S; Patel S
    J Cancer Res Ther; 2017; 13(6):964-967. PubMed ID: 29237960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prototype tobacco-associated oral squamous cell carcinoma classifier using RNA from brush cytology.
    Kolokythas A; Bosman MJ; Pytynia KB; Panda S; Sroussi HY; Dai Y; Schwartz JL; Adami GR
    J Oral Pathol Med; 2013 Oct; 42(9):663-9. PubMed ID: 23590359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear morphometry and AgNOR quantification: computerized image analysis on ovarian mucinous tumor imprints.
    Versa-Ostojić D; Stanković T; Stemberger-Papić S; Vrdoljak-Mozetic D; Manestar M; Krasević M
    Anal Quant Cytol Histol; 2008 Jun; 30(3):160-8. PubMed ID: 18630841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of oral premalignant and malignant lesions using cytomorphometry.
    Ramaesh T; Mendis BR; Ratnatunga N; Thattil RO
    Odontostomatol Trop; 1999 Mar; 22(85):23-8. PubMed ID: 11372099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exfoliative cytologic examinations in the early diagnosis of oral cancer.
    Bánóczy J
    Int Dent J; 1976 Dec; 26(4):398-404. PubMed ID: 1068977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AgNOR cut-point to distinguish mild and moderate epithelial dysplasia.
    Chattopadhyay A; Ray JG
    J Oral Pathol Med; 2008 Feb; 37(2):78-82. PubMed ID: 18197851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral potentially malignant disorders: clinical diagnosis and current screening aids: a narrative review.
    Parakh MK; Ulaganambi S; Ashifa N; Premkumar R; Jain AL
    Eur J Cancer Prev; 2020 Jan; 29(1):65-72. PubMed ID: 30921006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argyrophilic nucleolar organizer regions in inflammatory, premalignant, and malignant oral lesions: a quantitative and qualitative assessment.
    Elangovan T; Mani NJ; Malathi N
    Indian J Dent Res; 2008; 19(2):141-6. PubMed ID: 18445932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exfoliative cytology in screening for malignant and premalignant lesions in the buccal mucosa.
    Ramaesh T; Ratnatunga N; Mendis BR; Rajapaksa S
    Ceylon Med J; 1998 Dec; 43(4):206-9. PubMed ID: 10355174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas.
    Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
    J Pathol; 1997 Aug; 182(4):450-6. PubMed ID: 9306967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytologic and DNA-cytometric examination of oral lesions in lichen planus.
    Maraki D; Yalcinkaya S; Pomjanski N; Megahed M; Boecking A; Becker J
    J Oral Pathol Med; 2006 Apr; 35(4):227-32. PubMed ID: 16519770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral rinse-based cytology and conventional exfoliative cytology: a comparative study.
    Mulki S; Shetty P; Pai P
    J Cancer Res Ther; 2015; 11(1):129-35. PubMed ID: 25879350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biopsy vs. superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions.
    Furrer VE; Benitez MB; Furnes M; Lanfranchi HE; Modesti NM
    J Oral Pathol Med; 2006 Jul; 35(6):338-44. PubMed ID: 16762014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
    Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
    Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral precancer and cancer].
    López-López J; Omaña-Cepeda C; Jané-Salas E
    Med Clin (Barc); 2015 Nov; 145(9):404-8. PubMed ID: 25638423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer.
    Warnakulasuriya KA; Johnson NW
    J Oral Pathol Med; 1996 Mar; 25(3):97-103. PubMed ID: 9148038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Update review on prevention and early diagnosis in oral cancer].
    Hirshberg A; Calderon S; Kaplan I
    Refuat Hapeh Vehashinayim (1993); 2002 Jul; 19(3):38-48, 89. PubMed ID: 12242764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
    Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
    Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of exfoliative cytology in the diagnosis of malignant and precancerous lesions of oral mucosa].
    Bienengräber V; Stubbe M; Steder I
    Stomatol DDR; 1986 Jan; 36(1):12-8. PubMed ID: 3461584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.